Literature DB >> 21489373

Large outbreak of isoniazid-monoresistant tuberculosis in London, 1995 to 2006: case-control study and recommendations.

H Maguire1, S Brailsford, J Carless, M Yates, L Altass, S Yates, S Anaraki, A Charlett, S Lozewicz, M Lipman, G Bothamley.   

Abstract

We conducted a case–control study to examine risk factors for isoniazid-monoresistant Mycobacterium tuberculosis in an ongoing outbreak in London. Cases were defined as individuals with an isoniazid-monoresistant strain diagnosed from 1995 to the third quarter of 2006 with an indistinguishable restriction fragment length polymorphism (RFLP) or mycobacterial interspersed repetitive unit (MIRU)-variable number tandem repeats (VNTR) pattern who were resident in or had epidemiological links with London. Controls were all other individuals reported with tuberculosis to the Health Protection Agency London regional epidemiology unit or the HPA London TB Register during 2000 to 2005. Of 293 cases, 153 (52%) were sputum smear-positive compared with 3,266 (18%) of controls. Cases were more likely to be young adults (aged between 15 and 34 years), born in the United Kingdom (OR: 2.4; 95% CI: 1.7–3.4) and of white (OR: 2.9; 95% CI: 1.8–4.8) or black Caribbean (OR: 12.5; 95% CI: 7.7–20.4) ethnicity, a prisoner at the time of diagnosis (OR: 20.2; 95% CI: 6.7–60.6), unemployed (OR: 4.1; 95% CI: 3.0–5.6), or a drug dealer or sex worker (OR: 187.1; 95% CI: 28.4–1,232.3). A total of 113 (39%) of cases used drugs and 54 (18%) were homeless. Completion of treatment gradually improved in cases from 55% among those diagnosed up to the end of 2002 compared with 65% by the end of 2006. Treatment completion increased from 79% to 83% in controls from 2000 to 2005. There are complex social challenges facing many cases in this outbreak that need to be addressed if medical interventions are to be successful.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21489373

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  13 in total

1.  Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.

Authors:  M Gegia; T Cohen; I Kalandadze; L Vashakidze; J Furin
Journal:  Int J Tuberc Lung Dis       Date:  2012-04-09       Impact factor: 2.373

2.  Tuberculosis in UK cities: workload and effectiveness of tuberculosis control programmes.

Authors:  Graham H Bothamley; Michelle E Kruijshaar; Heinke Kunst; Gerrit Woltmann; Mark Cotton; Dinesh Saralaya; Mark A Woodhead; John P Watson; Ann L N Chapman
Journal:  BMC Public Health       Date:  2011-11-28       Impact factor: 3.295

3.  Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance.

Authors:  Giovanni Satta; Adam A Witney; Robert J Shorten; Magdalena Karlikowska; Marc Lipman; Timothy D McHugh
Journal:  BMC Med       Date:  2016-08-16       Impact factor: 8.775

4.  Recent TB transmission, clustering and predictors of large clusters in London, 2010-2012: results from first 3 years of universal MIRU-VNTR strain typing.

Authors:  Esther L Hamblion; Arnaud Le Menach; Laura F Anderson; Maeve K Lalor; Tim Brown; Ibrahim Abubakar; Charlotte Anderson; Helen Maguire; Sarah R Anderson
Journal:  Thorax       Date:  2016-08       Impact factor: 9.139

5.  Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study.

Authors:  Nicola Casali; Agnieszka Broda; Simon R Harris; Julian Parkhill; Timothy Brown; Francis Drobniewski
Journal:  PLoS Med       Date:  2016-10-04       Impact factor: 11.069

6.  Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.

Authors:  Renata Báez-Saldaña; Guadalupe Delgado-Sánchez; Lourdes García-García; Luis Pablo Cruz-Hervert; Marlene Montesinos-Castillo; Leticia Ferreyra-Reyes; Miriam Bobadilla-Del-Valle; Sergio Canizales-Quintero; Elizabeth Ferreira-Guerrero; Norma Téllez-Vázquez; Rogelio Montero-Campos; Mercedes Yanes-Lane; Norma Mongua-Rodriguez; Rosa Areli Martínez-Gamboa; José Sifuentes-Osornio; Alfredo Ponce-de-León
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

7.  Multiple large clusters of tuberculosis in London: a cross-sectional analysis of molecular and spatial data.

Authors:  Catherine M Smith; Helen Maguire; Charlotte Anderson; Neil Macdonald; Andrew C Hayward
Journal:  ERJ Open Res       Date:  2017-01-30

8.  Twenty years and counting: epidemiology of an outbreak of isoniazid-resistant tuberculosis in England and Wales, 1995 to 2014.

Authors:  Catherine M Smith; Suzan C M Trienekens; Charlotte Anderson; Maeve K Lalor; Tim Brown; Alistair Story; Hannah Fry; Andrew C Hayward; Helen Maguire
Journal:  Euro Surveill       Date:  2017-02-23

9.  Accuracy of Probabilistic Linkage Using the Enhanced Matching System for Public Health and Epidemiological Studies.

Authors:  Robert W Aldridge; Kunju Shaji; Andrew C Hayward; Ibrahim Abubakar
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

10.  Towards better guidance on caseload thresholds to promote positive tuberculosis treatment outcomes: a cohort study.

Authors:  Helen R Stagg; Ibrahim Abubakar; James Brown; Maeve K Lalor; H Lucy Thomas; Tehreem Mohiyuddin; Debora Pedrazzoli; Corinne S Merle
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.